Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.
Saved in:
| Title: | Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. |
|---|---|
| Authors: | Elewaut A; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Estivill G; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Bayerl F; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Castillon L; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Novatchkova M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Pottendorfer E; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Hoffmann-Haas L; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Schönlein M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Nguyen TV; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Lauss M; Lund University Cancer Center, Division of Oncology, Lund University, Lund, Sweden., Andreatta F; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Vulin M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Krecioch I; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Bayerl J; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Pedde AM; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Fabre N; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Holstein F; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Cronin SM; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria., Rieser S; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Laniti DD; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland., Barras D; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland., Coukos G; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland., Quek C; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Bai X; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Muñoz I Ordoño M; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Wiesner T; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Zuber J; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria., Jönsson G; Lund University Cancer Center, Division of Oncology, Lund University, Lund, Sweden., Böttcher JP; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany., Vanharanta S; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Obenauf AC; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria. anna.obenauf@imp.ac.at. |
| Source: | Nature [Nature] 2025 Jan; Vol. 637 (8046), pp. 716-725. Date of Electronic Publication: 2024 Nov 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39604727 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Elewaut+A%22">Elewaut A</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Estivill+G%22">Estivill G</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bayerl+F%22">Bayerl F</searchLink>; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Castillon+L%22">Castillon L</searchLink>; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Novatchkova+M%22">Novatchkova M</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Pottendorfer+E%22">Pottendorfer E</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hoffmann-Haas+L%22">Hoffmann-Haas L</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Schönlein+M%22">Schönlein M</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Nguyen+TV%22">Nguyen TV</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Lauss+M%22">Lauss M</searchLink>; Lund University Cancer Center, Division of Oncology, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Andreatta+F%22">Andreatta F</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Vulin+M%22">Vulin M</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Krecioch+I%22">Krecioch I</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bayerl+J%22">Bayerl J</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Pedde+AM%22">Pedde AM</searchLink>; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Fabre+N%22">Fabre N</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Holstein+F%22">Holstein F</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Cronin+SM%22">Cronin SM</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.; Vienna BioCenter, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Rieser+S%22">Rieser S</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Laniti+DD%22">Laniti DD</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barras+D%22">Barras D</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Coukos+G%22">Coukos G</searchLink>; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL), Lausanne, Switzerland.; Department of Oncology, University Hospital of Lausanne (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; Agora Research Center, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Quek+C%22">Quek C</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Bai+X%22">Bai X</searchLink>; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Muñoz+I+Ordoño+M%22">Muñoz I Ordoño M</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Wiesner+T%22">Wiesner T</searchLink>; Department of Dermatology, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Zuber+J%22">Zuber J</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Jönsson+G%22">Jönsson G</searchLink>; Lund University Cancer Center, Division of Oncology, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Böttcher+JP%22">Böttcher JP</searchLink>; Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Vanharanta+S%22">Vanharanta S</searchLink>; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Obenauf+AC%22">Obenauf AC</searchLink>; Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria. anna.obenauf@imp.ac.at. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220410462%22">Nature</searchLink> [Nature] 2025 Jan; Vol. 637 (8046), pp. 716-725. <i>Date of Electronic Publication: </i>2024 Nov 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0410462 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-4687 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200280836%22">00280836 </searchLink><i>NLM ISO Abbreviation: </i>Nature <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39604727 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41586-024-08257-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 716 Titles: – TitleFull: Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Elewaut A – PersonEntity: Name: NameFull: Estivill G – PersonEntity: Name: NameFull: Bayerl F – PersonEntity: Name: NameFull: Castillon L – PersonEntity: Name: NameFull: Novatchkova M – PersonEntity: Name: NameFull: Pottendorfer E – PersonEntity: Name: NameFull: Hoffmann-Haas L – PersonEntity: Name: NameFull: Schönlein M – PersonEntity: Name: NameFull: Nguyen TV – PersonEntity: Name: NameFull: Lauss M – PersonEntity: Name: NameFull: Andreatta F – PersonEntity: Name: NameFull: Vulin M – PersonEntity: Name: NameFull: Krecioch I – PersonEntity: Name: NameFull: Bayerl J – PersonEntity: Name: NameFull: Pedde AM – PersonEntity: Name: NameFull: Fabre N – PersonEntity: Name: NameFull: Holstein F – PersonEntity: Name: NameFull: Cronin SM – PersonEntity: Name: NameFull: Rieser S – PersonEntity: Name: NameFull: Laniti DD – PersonEntity: Name: NameFull: Barras D – PersonEntity: Name: NameFull: Coukos G – PersonEntity: Name: NameFull: Quek C – PersonEntity: Name: NameFull: Bai X – PersonEntity: Name: NameFull: Muñoz I Ordoño M – PersonEntity: Name: NameFull: Wiesner T – PersonEntity: Name: NameFull: Zuber J – PersonEntity: Name: NameFull: Jönsson G – PersonEntity: Name: NameFull: Böttcher JP – PersonEntity: Name: NameFull: Vanharanta S – PersonEntity: Name: NameFull: Obenauf AC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-4687 Numbering: – Type: volume Value: 637 – Type: issue Value: 8046 Titles: – TitleFull: Nature Type: main |
| ResultId | 1 |